Journal of Shandong University (Health Sciences) ›› 2020, Vol. 58 ›› Issue (12): 23-28.doi: 10.6040/j.issn.1671-7554.0.2020.0817

Previous Articles     Next Articles

miR-203 targeting Survivin to inhibit the proliferation, migration and invasion of ovarian cancer cells

WANG Baojin1, ZHAO Xinxin1, LI Xia1, MA Qian1, WANG Xinyue1, SUN Yang2, SHI Zhongna1   

  1. 1. Department of Gynecology, The Third Affiliated Hospital of Zhengzhou University, Henan International Joint Laboratory of Ovarian Malignancies, Zhengzhou 450052, Henan, China;
    2. Department of Gynecology, Fujian Provincial Hospital, Fuzhou 350001, Fujian, China
  • Published:2020-12-08

PDF (PC)

226

Abstract: Objective To investigate the effects of miR-203 targeting Survivin on the proliferation, migration and invasion of ovarian cancer cells SKOV3 and OVCAR3. Methods After miR-203 over-expressing group, Survivin over-expressing group and black control group of lentiviral vectors were constructed, the SKOV3 and OVCAR3 cells were transfected. After puromycin screening, the blank control group, miR-203 over-expressing group, Survivin over-expressing group, and miR-203 over-expressing plus Survivin group were established. The expressions of Survivin and epithelial-mesenchymal transition(EMT)-related proteins in each group were detected with Western blotting. The proliferation of cells was detected with MTT and plate clone formation assay. The cell migration and invasion were detected with Transwell assay. Results miR-203 over-expression inhibited the expressions of Survivin and EMT(P<0.05). MTT, plate clone formation and Transwell assay illustrated that, compared with the blank control group, the miR-203 over-expressing group had inhibited cell proliferation, migration, and invasion(P<0.05), while the Survivin over-expressing group reversed the inhibitory effects of miR-203(P<0.05). Conclusion miR-203 can inhibit EMT by targeting Survivin to inhibit the proliferation, migration, and invasion of ovarian cancer cells. The miR-203/Survivin/EMT axis is expected to be a new target for the treatment of ovarian cancer.

Key words: Ovarian cancer, miR-203, Survivin, Epithelial-mesenchymal transition

CLC Number: 

  • R737.31
[1] 陆衡, 刘延国, 李曙光, 等. YKL-40对卵巢癌SKOV-3细胞迁移能力的影响[J]. 山东大学学报(医学版), 2017, 55(1): 33-38. LU Heng, LIU Yanguo, LI Shuguang, et al. Regulation of epithelial ovarian carcinoma SKOV-3 cell migration by YKL-40 and the underlying mechanism [J]. Journal of Shandong University, 2017, 55(1): 33-38.
[2] Wu X, Liu X. Analysis of the expression of D-dimer, CD147 and miR203 and their correlation in gastric cancer[J]. Pak J Med Sci, 2019, 35(2): 443-447.
[3] Piasecka D, Braun M, Kordek R, et al. MicroRNAs in regulation of triple-negative breast cancer progression[J]. J Cancer Res Clin Oncol, 2018, 144(8): 1401-1411.
[4] You A, Fu L, Li Y, et al. MicroRNA-203 restrains epithelial-mesenchymal transition, invasion and migration of papillary thyroid cancer by downregulating AKT3[J]. Cell Cycle, 2020, 19(10): 1105-1121.
[5] Wang Q, Yang G, Jiang Y, et al. XB130, regulated by miR-203, miR-219, and miR-4782-3p, mediates the proliferation and metastasis of non-small-cell lung cancer cells[J]. Mol Carcinog, 2020, 59(5): 557-568.
[6] Zeng S, Liu S, Feng J, et al. MicroRNA-32 promotes ovarian cancer cell proliferation and motility by targeting SMG1[J]. Oncol Lett, 2020, 20(1): 733-741.
[7] Zhang Y, Zhou SY, Yan HZ, et al. miR-203 inhibits proliferation and self-renewal of leukemia stem cells by targeting survivin and Bmi-1[J]. Sci Rep, 2016, 6: 19995. doi:10.1038/srep19995.
[8] Le F, Luo P, Ouyang Q, et al. LncRNA WT1-AS downregulates Survivin by upregulating miR-203 in papillary thyroid carcinoma[J]. Cancer Manag Res, 2020, 12: 443-449. doi: 10.2147/CMAR.S232294.eCollection 2020.
[9] Wang B, Li X, Zhao G, et al. miR-203 inhibits ovarian tumor metastasis by targeting BIRC5 and attenuating the TGFβ pathway[J]. J Exp Clin Cancer Res, 2018, 37(1): 235-243.
[10] Qian XQ, Tang SS, Shen YM, et al. Notch1 affects chemo-resistance through regulating epithelial-mesenchymal transition(EMT)in epithelial ovarian cancer cells[J]. Int J Med Sci, 2020, 17(9): 1215-1223.
[11] Scalici JM, Arapovic S, Saks EJ, et al. Mesothelium expression of vascular cell adhesion molecule-1(VCAM-1)is associated with an unfavorable prognosis in epithelial ovarian cancer(EOC)[J]. Cancer, 2017, 123(6): 977-984.
[12] Chen X, Zhang J, Zhang Z, et al. Cancer stem cells, epithelial-mesenchymal transition, and drug resistance in high-grade ovarian serous carcinoma[J]. Hum Pathol, 2013, 44(11): 2373-2384.
[13] Ghafouri-Fard S, Shoorei H, Taheri M. miRNA profile in ovarian cancer[J]. Exp Mol Pathol, 2020, 113: 104381. doi:10.1016/j.yexmp.2020.104381.
[14] Kim JS, Choi DW, Kim CS, et al. MicroRNA-203 induces apoptosis by targeting bmi-1 in YD-38 oral cancer cells[J]. Anticancer Res, 2018, 38(6): 3477-3485.
[15] Zhang K, Dai L, Zhang B, et al. miR-203 is a direct transcriptional target of E2F1 and causes G1 arrest in esophageal cancer cells[J]. J Cell Physiol, 2015, 230(4): 903-910.
[16] Gao P, Wang S, Jing F, et al. microRNA-203 suppresses invasion of gastric cancer cells by targeting ERK1/2/Slug/ E-cadherin signaling[J]. Cancer Biomark, 2017, 19(1): 11-20.
[17] Deng B, Wang B, Fang J, et al. MiRNA-203 suppresses cell proliferation, migration and invasion in colorectal cancer via targeting of EIF5A2[J]. Sci Rep, 2016, 6: 28301. doi:10.1038/srep28301.
[18] Chi Y, Jin Q, Liu X, et al. miR-203 inhibits cell proliferation, invasion, and migration of non-small-cell lung cancer by downregulating RGS17[J]. Cancer Sci, 2017, 108(12): 2366-2372.
[19] Shen J, Zhang J, Xiao M, et al. miR-203 Suppresses bladder cancer cell growth and targets twist[J]. Oncol Res, 2018, 26(8): 1155-1165.
[20] Lin J, Wang L, Gao J, et al. MiR-203 inhibits estrogen-induced viability, migration and invasion of estrogen receptor α-positive breast cancer cells[J]. Exp Ther Med, 2017, 14(3): 2702-2708.
[21] Martínez-García D, Manero-Rupérez N, Quesada R, et al. Therapeutic strategies involving survivin inhibition in cancer[J]. Med Res Rev, 2019, 39(3): 887-909.
[22] He XJ, Zhang Q, Ma LP, et al. Aberrant alternative polyadenylation is responsible for Survivin up-regulation in ovarian cancer[J]. Chin Med J(Engl), 2016, 129(10): 1140-1146.
[23] Mittal V. Epithelial mesenchymal transition in tumor metastasis[J]. Annu Rev Pathol, 2018, 13: 395-412. doi: 10.1146/annurev-pathol-020117-043854.
[24] Qian XQ, Tang SS, Shen YM, et al. Notch1 affects chemo-resistance through regulating epithelial-mesenchymal transition(EMT)in epithelial ovarian cancer cells[J]. Int J Med Sci, 2020, 17(9): 1215-1223.
[25] Wang Z, Liu Y, Wang M, et al. Effects of miR-492 on migration, invasion, EMT and prognosis in ovarian cancer by targeting SOX7[J]. J buon, 2020, 25(2): 797-804.
[26] Zhao G, Guo Y, Chen Z, et al. miR-203 functions as a tumor Suppressor by inhibiting epithelial to mesenchymal transition in ovarian cancer[J]. J Cancer Sci Ther, 2015, 7(2): 34-43.
[1] WANG Lin-Lin, SUN Mei-Li, SUN Yu-Ping, ZHANG Nan, LIU Chuan-Yong. Expressions of α-Tubulin and γ-Tubulin in human Glioma and their relation with Survivin [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 103-.
[2] HUANG Fang, KANG Rui, TUN Chun-Lin. Expressions of VEGF-C，nuclear factor-kappa B and  Survivin in nasopharyngeal carcinoma and their clinical implications [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 83-.
[3] LU Heng, LIU Yanguo, LI Shuguang, CHEN Xiaokang, TIAN Qi, YI Cuihua, WANG Xiuwen. Regulation of epithelial ovarian carcinoma SKOV-3 cell migration by YKL-40 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 33-38.
[4] ZHAO Lu, JIAO Jun, ZHANG Teng, JIAO Xinlin, CUI Baoxia. Expression of LXRα in ovarian carcinoma and effects of T0901317 on SKOV3 cell line [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 49-53.
[5] XIAO Junchao, JIANG Wen, NAN Hui, WANG Peirong. A recombinant adenovirus fiber knob protein sensitizes ovarian cancer cells to cetuximab therapy [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(5): 1-5.
[6] ZHAO Yunxia, SONG Jing, ZHANG Cancan, LIN Xueyan, WEI Wei, TIAN Yongjie. CXXC4 promotes sensitivity to chemotherapy drugs in epithelial ovarian cancer cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(3): 24-29.
[7] XU Zhihong, WU Xiaohua, YAO Tiezhu, WANG Xiaoxiang, DUAN Xiaoyang, SHI Jian. Relationship between mir-99a expression and prognosis of epithelial ovarian cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(3): 77-80.
[8] ZHENG Hui, WEI Guangwei. Mechanical function of HIPK2 in epithelial-mesenchymal transition and metastasis of non-small cell lung cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(11): 7-12.
[9] CUI Yong, ZHANG Rongxiang, WANG Fuli, WANG Guoying, FENG Jianlin, ZHANG Haixia. Clinical efficacy of BSD2000 deep hyperthermia combined with chemotherapy of TP regimen for advanced ovarian cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(7): 53-57.
[10] YU Shuping, LI Xuefei, WANG Dan, WANG Yukun. Expressions of PDCD4 and survivin in condyloma acuminatum, Bowenoid papulosis, Bowen disease and squamous cell carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(7): 82-86.
[11] ZENG Renren, ZHANG Junhua, ZHANG Yinxu. The role of miR-485-5p in human colorectal cancer HCT116 cell invasion by regulating survivin expression [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(6): 23-27.
[12] GU Xu, WANG Xiaqing, REN Wanhua, QIN Chengyong, HAN Guoqing. Expression and clinical significance of NPRL2 and Survivin in hepatocellular carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(6): 68-72.
[13] CHEN Jing, LI Chunyan, ZHAO Miaoqing, CUI Jingjing, ZHANG Na, FU Yibing. Expression of EZH2 protein and its role in ovarian epithelial tumor [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(2): 65-70.
[14] LI Hongxia, DONG Lei, JIANG Jiong, WANG Xinyang. Effects of peptide YY on apoptosis of human pancreatic cancer cell line Miapaca-2 in vitro [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(12): 7-11.
[15] QIU Huihui1， YE Liping1， WEN Youfeng2， LI Dan1， SONG Jia1. Effects of IL-6 on the expressions of bcl-2，cyclinD1 and VEGF in ovarian cancer cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(6): 17-21.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd